Scri-Cbci — Denver, Colorado

Scri-Cbci is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Scri-Cbci has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma, Myeloma.

Sponsors: Fate Therapeutics.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Scri-Cbci?

Scri-Cbci has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Scri-Cbci conducted?

Scri-Cbci has 1 clinical trials on record. Their work covers Multiple Myeloma, Myeloma.

Is Scri-Cbci accredited by Crixeo Health?

Scri-Cbci has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Scri-Cbci?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.